Seres Therapeutics News and Activities

Presence

Seres Therapeutics develops microbiome medicines for digestive and immune-related diseases. It provides therapeutic programs, clinical development services, and related research for patients, healthcare providers, and biopharmaceutical partners.

Seres Therapeutics products and services overview:

Microbiome therapeutics
Drug development
Clinical research
Biotechnology services

Revenue: ~$50 million

Employees: 140

Headquarters: Cambridge, United States (USA)

Seres Therapeutics is one of the...

Seres Therapeutics is a company listed under the stock ticker MCRB (US).

Executives

View the org chart displaying its 24 main executives

Most searched biographies at Seres Therapeutics

Popular executive movements at Seres Therapeutics

Hans-Juergen Woerle, Director, has left the company (posted on June 2 2026).
Kelly Brady who was Senior Vice President, Clinical Development, becomes Chief Operating Officer (posted on May 20 2026).
Marella Thorell who was Co-Chief Executive Officer and Chief Financial Officer, becomes Chief Financial Officer (posted on March 3 2026).

Click here to view some more movements at Seres Therapeutics

Create your alert
to follow the executive moves at Seres Therapeutics.